Hawkins (HWKN) to Release Quarterly Earnings on Wednesday

Hawkins (NASDAQ:HWKN) is projected to issue its Q3 2026 results after the market closes on Wednesday, January 28th. Analysts expect the company to announce earnings of $0.75 per share and revenue of $252.51 million for the quarter. Interested persons can check the company’s upcoming Q3 2026 earning summary page for the latest details on the call scheduled for Wednesday, January 28, 2026 at 4:10 PM ET.

Hawkins (NASDAQ:HWKN) last issued its quarterly earnings data on Wednesday, October 29th. The specialty chemicals company reported $1.08 earnings per share for the quarter, missing the consensus estimate of $1.24 by ($0.16). The firm had revenue of $280.43 million during the quarter, compared to the consensus estimate of $284.42 million. Hawkins had a net margin of 7.95% and a return on equity of 17.42%. On average, analysts expect Hawkins to post $4 EPS for the current fiscal year and $4 EPS for the next fiscal year.

Hawkins Trading Down 1.1%

Hawkins stock opened at $154.72 on Monday. Hawkins has a 52-week low of $98.30 and a 52-week high of $186.15. The company has a quick ratio of 1.49, a current ratio of 2.43 and a debt-to-equity ratio of 0.53. The firm has a market capitalization of $3.23 billion, a price-to-earnings ratio of 38.87, a PEG ratio of 2.39 and a beta of 0.86. The firm has a 50-day moving average price of $142.49 and a two-hundred day moving average price of $156.62.

Wall Street Analysts Forecast Growth

Several brokerages have recently issued reports on HWKN. Zacks Research upgraded Hawkins from a “strong sell” rating to a “hold” rating in a research report on Friday, January 2nd. Weiss Ratings downgraded Hawkins from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Monday, January 12th. Finally, BWS Financial reissued a “buy” rating and issued a $200.00 price target on shares of Hawkins in a research note on Monday, November 3rd. Two investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $162.50.

Insider Activity at Hawkins

In related news, VP Drew M. Grahek purchased 1,587 shares of the firm’s stock in a transaction that occurred on Monday, November 3rd. The stock was acquired at an average price of $126.34 per share, for a total transaction of $200,501.58. Following the transaction, the vice president directly owned 39,640 shares of the company’s stock, valued at $5,008,117.60. This trade represents a 4.17% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available at the SEC website. 4.10% of the stock is currently owned by corporate insiders.

Institutional Trading of Hawkins

A number of hedge funds have recently bought and sold shares of HWKN. Wasatch Advisors LP boosted its holdings in shares of Hawkins by 10.9% in the third quarter. Wasatch Advisors LP now owns 420,569 shares of the specialty chemicals company’s stock worth $76,846,000 after buying an additional 41,184 shares during the period. Invesco Ltd. lifted its position in shares of Hawkins by 44.4% in the 3rd quarter. Invesco Ltd. now owns 407,793 shares of the specialty chemicals company’s stock valued at $74,512,000 after acquiring an additional 125,444 shares in the last quarter. Raymond James Financial Inc. boosted its stake in Hawkins by 32.9% in the 3rd quarter. Raymond James Financial Inc. now owns 96,329 shares of the specialty chemicals company’s stock worth $17,601,000 after purchasing an additional 23,841 shares during the period. Public Sector Pension Investment Board grew its position in Hawkins by 6.9% during the 2nd quarter. Public Sector Pension Investment Board now owns 64,552 shares of the specialty chemicals company’s stock worth $9,173,000 after purchasing an additional 4,157 shares in the last quarter. Finally, Ameriprise Financial Inc. grew its position in Hawkins by 3.1% during the 3rd quarter. Ameriprise Financial Inc. now owns 62,602 shares of the specialty chemicals company’s stock worth $11,439,000 after purchasing an additional 1,876 shares in the last quarter. 69.71% of the stock is owned by hedge funds and other institutional investors.

About Hawkins

Hawkins, Inc (NASDAQ: HWKN) is a specialty chemical company that produces and distributes water-treatment and industrial chemicals across North America. Founded in 1938 and headquartered in Roseville, Minnesota, the company has built a network of manufacturing facilities and distribution centers that serve municipal, industrial and commercial customers. As a publicly traded entity, Hawkins leverages its long-standing presence in the chemical distribution industry to provide tailored solutions for complex water-treatment challenges and specialty chemical needs.

Hawkins’ product portfolio encompasses a wide range of chemicals, including sodium hypochlorite, sodium hydroxide, hydrogen peroxide, chlorine, acids and specialty blends.